Related Experiment Video

Updated: Jul 15, 2025

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
19:53

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer

Published on: March 1, 2015

105.9K

Facial Nerve Palsy After Chimeric Antigen Receptor T-Cell Therapy

Alexis B Richards1, Geoffrey P Fletcher2, Javier L Munoz1

  • 1Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.

Mayo Clinic Proceedings
|October 4, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration
00:05

Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration

Published on: May 5, 2020

7.5K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

Related Experiment Videos

Last Updated: Jul 15, 2025

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
19:53

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer

Published on: March 1, 2015

105.9K
Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration
00:05

Facial Nerve Surgery in the Rat Model to Study Axonal Inhibition and Regeneration

Published on: May 5, 2020

7.5K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K

Articles linked to this work by shared authors, journal, and citation graph.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026.

Mayo Clinic proceedings·2026

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Blood cancer journal·2026

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Blood advances·2026

Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.

American journal of hematology·2025

Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide.

Med (New York, N.Y.)·2024

The Optimal Timing for Patients With Acute Myocardial Infarction to Safely Undergo Elective Non-Cardiac Surgery: A Retrospective Cohort Study.

Mayo Clinic proceedings·2026

Topical Therapy for the Internist: A Practical Framework for Safer Prescribing.

Mayo Clinic proceedings·2026

Treatment of Parkinson Disease.

Mayo Clinic proceedings·2026

Navigating Protein-Losing Enteropathy: A Stepwise Approach for Primary Care Clinicians.

Mayo Clinic proceedings·2026

The Impact of Animal-Assisted Treatment on Inpatient Stroke Rehabilitation.

Mayo Clinic proceedings·2026

MRI-Negative Posterior Reversible Encephalopathy Syndrome: Comparison of Hypertensive Encephalopathy With and Without Vasogenic Edema.

Mayo Clinic proceedings·2026

Torque Teno Virus (TTV) Viremia as a Biomarker of Immune Reconstitution and Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.

Journal of medical virology·2026

Retrospective cohort study of epitope-based virtual crossmatch allocation in a public transplant system (Pernambuco, Brazil).

Frontiers in immunology·2026

First Moroccan ABO-Incompatible Living Donor Kidney Transplantation: Successful Desensitization Without Intravenous Immunoglobulin.

Transplantation proceedings·2026

Human Milk Oligosaccharide (2'-FL) Modifies the Gut Microbiome in Children after Bone Marrow Transplant.

Blood·2026

Autologous immune system reset for kidney allograft acceptance: mechanisms, evidence, and a testable reconstitution-window model.

Frontiers in medicine·2026

Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.

Transplantation proceedings·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us